Looking to Lower Your Risk of Alzheimer’s? It Doesn’t Involve a Blood Test

The recent clearance of four blood tests by the US Food and Drug Administration (FDA) to diagnose Alzheimer’s disease has sparked renewed interest in predicting and preventing cognitive decline. While these tests may hold promise for those already showing symptoms, experts warn against their use among asymptomatic individuals, emphasizing instead that addressing potentially preventable brain risks is key to long-term health.

The FDA-approved blood tests measure the presence of abnormal proteins associated with Alzheimer’s, specifically beta-amyloid and tau. However, a positive test result merely indicates an increased risk factor, not a guarantee of future cognitive trouble. Dr. Nicholas Ashton, a testing expert from Banner Health in Arizona, cautions that many older adults harbor high levels of amyloid without ever showing symptoms.

The desire to know one’s Alzheimer’s risk has led some individuals to seek out these tests prematurely. Mark Yost, a 60-year-old Phoenix resident, volunteered for a blood test study after experiencing anxiety about his own risk. He received an intermediate result, indicating possible amyloid buildup without a significant increase in risk. The uncertainty left him feeling disappointed and uncertain about what to do next.

In reality, there is no one-size-fits-all solution for mitigating Alzheimer’s risk. A major trial found that healthier habits – including regular exercise, resistance training, and following the MIND diet – can slow age-related cognitive decline in older adults at increased risk of dementia. Experts emphasize the importance of addressing potentially preventable brain risks, particularly during middle age.

The NYU study highlights the significant benefits of avoiding high blood pressure, Type 2 diabetes, and smoking. By delaying or preventing these conditions, individuals can live nearly 13 years longer without developing dementia – a testament to the critical role that lifestyle choices play in brain health. Dr. Josef Coresh notes that aggressively treating high blood pressure has a substantial payoff for brain health.

Rather than relying on a single diagnostic tool, people should focus on adopting a comprehensive approach to brain health. This includes physical activity, mental stimulation, social engagement, and stress management. By prioritizing prevention over prediction, policymakers and healthcare professionals can better support individuals in maintaining cognitive function throughout their lives.

The ongoing clinical trials aiming to determine whether existing Alzheimer’s treatments may also be effective in preventing symptoms are a promising development. However, these findings will likely change testing advice and raise further questions about the role of blood tests in Alzheimer’s prevention.

Ultimately, it’s time for a more nuanced conversation about brain health and Alzheimer’s risk. Rather than fixating on diagnostic tools, we should focus on empowering individuals with actionable steps to maintain their cognitive well-being – a proactive approach that can only benefit from prioritizing prevention over prediction.